Similarly, the negative transductivity sensitivities of p53 in AML and MDS cells were due to the genetic mutations of the interaction sites between JNK and p53, and between RSK2 and p53, which lead to the dysregulation of apoptosis in leukemic subtypes. This evidence concerns the gene TP53 and myelodysplastic syndrome.